CURRENT DEVELOPMENTS AT HAPA
Expopharm: HAPA presents an impressive booth at Expopharm, Europe‘s largest trade fair for the pharmaceutical industry. We will showcase our expanded range of cannabis genotype varieties, introduce new formulations and innovative dosage forms. The event provides an excellent platform to strengthen our position in the market and present our latest offerings.
Advisory Board: We are pleased to announce the formation of our Advisory Board, comprised of industry experts and opinion leaders. This advisory board will provide valuable insight and support to inform our strategic decision-making processes, as well as ensure HAPA remains at the forefront of the cannabis industry.
HAPA 2.0: We are working on the launch of a range of prescription medicines in various dosage forms. These products will be based on extensive research and development and will offer our customers a wider range of therapy options.
Meta-study summary on Ginkgo and Cannabis BPSD: We have produced a poster on the links between ginkgo and cannabis in the context of the treatment of BPSD (Behavioral and Psychological Symptoms of Dementia). These research findings are very promising and can lead to new therapeutic approaches.
Developments in Northern Macedonia: In Northern Macedonia, we are expanding and improving our existing production facilities.
Developments in Germany: We recorded a significant increase in sales in the pharmacy business. In addition, we have significantly improved our customer acquisition, particularly in the pharmacy sector. We are also in advanced discussions about further expansion into other European countries. The legalization of medical cannabis and the strengthening of the medical sector are important focus points of our strategy.